Effective prevention of interstitial rejection crises in immunological high risk patients following renal transplantation: use of high doses of the new monoclonal antibody BMA 031.
Dendorfer
U
U
Division of Transplant Surgery, Klinikum Grosshadern, University of Munich, FRG.
Hillebrand
G
G
Kasper
C
C
Smely
S
S
Weschka
M
M
Hammer
C
C
Racenberg
J
J
Gurland
H J
HJ
Land
W
W
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D001379:Azathioprine / Q000627:therapeutic use; D003524:Cyclosporins / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D006084:Graft Rejection; D006085:Graft Survival; D006801:Humans; D007165:Immunosuppression Therapy; D007432:Intraoperative Period; D016030:Kidney Transplantation / Q000276:immunology*; D008775:Methylprednisolone / Q000627:therapeutic use
D000911:Antibodies, Monoclonal; D003524:Cyclosporins; D001379:Azathioprine; D008775:Methylprednisolone